| |
| |
|
| Insider
Information: |
Dickinson Andrew D |
| Relationship: |
Chief Financial Officer |
| City: |
Westminster |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
134,983 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,649,711 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
134,983 |
|
|
| Total
Value |
$8,649,711 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Financial Officer |
2024-03-10 |
134,983 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2019-11-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,133 |
6,060 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,818 |
11,191 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
769 |
11,756 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,646 |
15,046 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,306 |
15,661 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-11-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,046 |
17,685 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2021-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,818 |
33,081 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,794 |
36,701 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2021-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,646 |
38,576 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2021-11-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,913 |
38,885 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2022-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,817 |
60,473 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2022-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,901 |
67,607 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2022-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,672 |
69,025 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2022-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,027 |
68,083 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2022-11-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,912 |
69,519 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2022-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,027 |
69,695 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2023-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,817 |
105,773 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,419 |
116,037 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,618 |
74,920 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2023-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,619 |
110,206 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2023-11-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,912 |
105,915 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2023-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,617 |
107,728 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,732 |
139,488 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial OfficerOf |
• – – |
2019-11-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,927 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2019-11-10 |
4 |
D |
$65.38 |
$34,063 |
D/D |
(521) |
5,539 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
